Document Detail

Myocardial energetics in cardiac hypertrophy.
MedLine Citation:
PMID:  11985549     Owner:  NLM     Status:  MEDLINE    
1. This review is presented with the intent of illustrating the representative studies of functional and myocardial energetic consequences of hearts with postinfarction left ventricular (LV) remodelling or with concentric hypertrophy and diastolic LV dysfunction in porcine models. 2. Both eccentric and concentric cardiac hypertrophy are associated with the abnormal myocardial energetics that are most severe in hearts with congestive heart failure (CHF). Presently, these abnormalities cannot be satisfactorily explained to be the cause(s) of the dysfunction of failing hearts or cause the progress from compensated cardiac hypertrophy to CHF. 3. Mechanisms governing abnormal myocardial high-energy phosphate (HEP) metabolism in hearts with cardiac hypertrophy and CHF are unclear. Myocardial energy metabolism studies use both kinetic and thermodynamic models. The thermodynamic studies examine the myocardial steady state levels of high- and low-energy phosphate, which indicate myocardial energy state or phosphorylation potential that is defined by the ratio of [ATP]/([ADP][Pi]). The kinetics studies examine the reaction velocity that is regulated by: (i) quantity and activity of the key enzymes; (ii) the concentrations of all the substrates and products; and (iii) the Michaelis-Menten constants of each substrate of the reaction. 4. Significant alterations in myocardial concentrations of phosphocreatine (PCr), ATP and ADP, myocardial oxidative phosphorylation (OXPHOS) protein expression and substrate preference are found in hearts with postinfarction LV remodelling and CHF. However, to define a causal relationship is a different matter. 5. Future studies of animal models of LV hypertrophy or heart failure using gene manipulation may provide additional insights to answer the persisting question of whether limitations of ATP synthetic or transport capacities contribute to the pathogenesis of LV remodelling or failure.
Jianyi Zhang
Related Documents :
2157339 - The prevention of congestive heart failure: left ventricular dilation and its management.
19741299 - Cdc42 is an antihypertrophic molecular switch in the mouse heart.
6450479 - Ultrastructural morphometric analysis of human myocardial left ventricles with mitral i...
10334449 - Volume overload hypertrophy of the newborn heart slows the maturation of enzymes involv...
2137729 - Functional and morphological characteristics of compensated and decompensated cardiac h...
8675259 - Association of carotid atherosclerosis with electrocardiographic myocardial ischemia an...
20450849 - Can we improve outcomes in patients with previous coronary artery bypass surgery admitt...
438049 - Myocarditis of probable viral origin in pups of weaning age.
17255859 - Levosimendan improves right ventriculovascular coupling in a porcine model of right ven...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  Clinical and experimental pharmacology & physiology     Volume:  29     ISSN:  0305-1870     ISO Abbreviation:  Clin. Exp. Pharmacol. Physiol.     Publication Date:  2002 Apr 
Date Detail:
Created Date:  2002-05-02     Completed Date:  2002-09-11     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0425076     Medline TA:  Clin Exp Pharmacol Physiol     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  351-9     Citation Subset:  IM    
Department of Medicine, University of Minnesota, Minneapolis, Minnesota 55455, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiomegaly / metabolism*,  pathology
Energy Metabolism / physiology*
Myocardium / metabolism*,  pathology
Grant Support

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Mitochondrial proteins in hypertrophy and atrophy: a transcript analysis in rat heart.
Next Document:  Capsazepine partially inhibits neurally mediated gastric mucus secretion following activation of pro...